Thrombin Generation During Cardiopulmonary Bypass Using Heparin-Coated or Standard Circuits

References

• Bar-Shavit R, Eldor A, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix. J Clin Invest 1989; 84: 1096–1104
   PubMed Web of Science ®Google Scholar
• Boisclair M D, Lane D A, Philippou H, Esnouf P, Sheikh S, Hunt B, Smith K J. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82: 3350–3357
   PubMed Web of Science ®Google Scholar
• Boisclair M D, Lane D A, Philippou H, Sheikh S, Hunt B. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F 1+2. Thromb Haemost 1993; 70: 253–258
   PubMed Web of Science ®Google Scholar
• Borowiec J, Thelin S, Bagge L, Hultman J, Hansson H. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose. Scand J Thor Cardiovasc Surg 1992; 26: 177–185
   PubMed Web of Science ®Google Scholar
• Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson H E. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 104: 642–647
   PubMedGoogle Scholar
• Borowiec J, Thelin S, Bagge L, van der Linden J, Thörnö E, Hansson H. Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery—a clinical study Uppsala. J Med Sci 1992; 97: 55–66
   Google Scholar
• Brister S J, Ofosu F A, Buchanan M R. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant. Thromb Haemost 1993; 70: 259–262
   PubMedGoogle Scholar
• Chenoweth D E, Cooper S W, Hugli T E, Stewart R W, Blackstone E H, Kirklin J W. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497–503
   PubMed Web of Science ®Google Scholar
• Conover W J. Practical nonparametric statistics. 2nd Ed. John Wiley & Sons, New York 1980; 299–305
   Google Scholar
• Elgue G, Blombäck M, Olsson P, Riesenfeld J. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin. Thromb Haemost 1993; 70: 289–293
   PubMed Web of Science ®Google Scholar
• Furie B, Furie B C. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 800–806
   PubMed Web of Science ®Google Scholar
• Gu Y J, van Oeveren W, van der Kamp K WHJ, Akkerman C, Boonstra P W, Wildevuur C RH. Heparin-coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass. Perfusion 1991; 6: 221–225
   Google Scholar
• Halvorsen H, Olsen J O, østerud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 1993; 54: 275–282
   PubMed Web of Science ®Google Scholar
• Hogg P J, Jackson C M. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy. Proc Natl Acad Sci USA 1989; 86: 3619–3623
   PubMed Web of Science ®Google Scholar
• Irvine L, Sundaram S, Courtney J M, Taggart D P, Wheatley D J, Lowe G DO. Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass. ASAIO Trans 1991; 37: 569–571
   PubMedGoogle Scholar
• Kappelmayer J, Bernabei A, Edmunds L H, Jr., Edgington T S, Colman R W. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 1993; 72: 1075–1081
   PubMed Web of Science ®Google Scholar
• Kirklin J K, Westaby S, Blackstone E H, Kirklin J W, Chenoweth D E, Pacifico A D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–857
   PubMed Web of Science ®Google Scholar
• Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Dev Artif Organs 1983; 11: 161–173
   PubMed Web of Science ®Google Scholar
• Mottaghy K, Oedekoven B, Pöppel K, Bruch-müller K, Kovacs B, Spahn A, Geisen C. Heparin free long-term extracorporeal circulation using bioactive surfaces. ASAIO Trans 1989; 35: 635–637
   PubMedGoogle Scholar
• Muhlfelder T, Niemetz J, Kreutzer D, Beebe D. C5 chemotactic fragment induces leukocyte production of tissue factor activity. J Clin Invest 1979; 63: 147–150
   PubMed Web of Science ®Google Scholar
• Nilsson L, Brunnkvist S, Nilsson U, Nyström S, Tydén H, Venge P, Åberg T. Activation of inflammatory systems during cardiopulmonary bypass. Scand J Thor Cardiovasc Surg 1988; 22: 51–53
   PubMed Web of Science ®Google Scholar
• Pekna M, Hagman L, Haldén E, Nilsson U R, Nilsson B, Thelin S. Complement activation during cardiopulmonary bypass: effects of immobilised heparin. Ann Thorac Surg 1994; 58: 421–424
   PubMedGoogle Scholar
• Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III-complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101–106
   PubMed Web of Science ®Google Scholar
• Pelzer H, Schwarz A, Stüber W. Determination of human prothrombin activation fragment 1+2 in plasma with antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153–159
   PubMed Web of Science ®Google Scholar
• Rapaport S I. The regulation of blood coagulation in normal hemostasis. 2nd symposium on new aspects of hemophilia treatment., U Hedner. Medicom, Bussum 1991; 5–14
   Google Scholar
• Riegel W, Spillner G, Schlosser V, Hörl W H. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988; 95: 1014–1019
   PubMed Web of Science ®Google Scholar
• Rinder C S, Bonan J L, Rinder H M, Mathew J, Hines R, Smith B R. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201–1205
   PubMed Web of Science ®Google Scholar
• Rinder C S, Mathew J P, Rinder H M, Bonan J, Ault K A, Smith B R. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991; 75: 563–570
   PubMedGoogle Scholar
• Swain J A. Cardiac surgery and the brain. N Engl J Med 1993; 329: 1119–1120
   PubMed Web of Science ®Google Scholar
• Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989; 3: 181–188
   PubMedGoogle Scholar
• Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68: 250–252
   PubMedGoogle Scholar
• Thelin S, Bagge L, Hultman J, Borowiec J, Nilsson L, Thorelius J. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur J Cardiothorac Surg 1991; 5: 486–491
   PubMedGoogle Scholar
• Tong S D, Rolfs M R, Hsu L C. Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits. ASAIO Trans 1990; 36: M654–M656
   Google Scholar
• Videm V, Nilsson L, Venge P, Svennevig J L. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991; 15: 90–95
   PubMed Web of Science ®Google Scholar
• Von Segesser L K, Weiss B M, Garcia E, Gallino A, Turina M. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardio-thorac Surg 1990; 4: 639–643
   PubMed Web of Science ®Google Scholar
• Wachtfogel Y T, Kucich U, Greenplate J, Gluszko P, Abrams W, Weinbaum G, Wenger R K, Rucinski B, Niewiarowski S, Edmunds L H, Jr., Colman R W. Human neutrophil degranulation during extracorporeal circulation. Blood 1987; 69: 324–330
   PubMed Web of Science ®Google Scholar
• østerud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes. J Leukoc Biol 1992; 51: 462–465
   PubMed Web of Science ®Google Scholar